Peptide • Metabolism, weight & diabetes
Tesamorelin
What it is, the potential benefits being studied, and what the evidence supports right now.
Well established•Used medically for a specific purpose•Checked 2026-08-21
01 • Start here
Potential benefits being studied.
Reducing excess abdominal fat in adults with HIV and lipodystrophy.
- Weight & body composition
- Condition-specific research
02 • Why it stands out
The simple explanation.
Tesamorelin is a growth-hormone-releasing peptide shown to reduce deep abdominal fat in a specific medical setting.
03 • Research highlight
Why researchers are interested.
It shows how a targeted peptide signal can create a measurable body-composition change in the people it was designed to help.
Evidence detailsStudy limits, status, and safety context
Study summary: Controlled trials support reduction of visceral adipose tissue in the labeled population.
What to keep in mind: The label states it is not indicated for general weight-loss management; evidence does not establish broad anti-aging use.
Potential benefits describe research questions, not a promise that a product will produce the same result in a person.